Maryann Kwa is a Hematology physician affiliated with NYU Langone Health. OpenAlex indexes 46 publications with 1,247 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZenecaProgram year20252 paymentsResearch$126,201openpaymentsdata.cms.gov ↗
- PfizerProgram year20251 paymentResearch$10,000openpaymentsdata.cms.gov ↗
- Stemline Therapeutics Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A multicenter, phase 1/2 trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in hormone receptor–positive, HER2-positive metastatic breast cancer (ASPIRE)
JNCI Journal of the National Cancer Institute
2026 - Comparing Gemini’s Food Category Classification Accuracy in Chinese American and Non-Hispanic White Breast Cancer Survivors
Current Developments in Nutrition
2026 - Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study
Journal of Cancer Research and Clinical Oncology
2025 - Ultrasound‐Guided Endometrial Aspiration and Immunohistochemistry for Detecting Focal Metastatic Cancer
Journal of Clinical Ultrasound
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Faith Davies, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Jaroslaw Maciejewski, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”